defenseworld.net · 28 jul

American Capital Management Inc. Has $59.58 Million Position in ResMed Inc. $RMD

American Capital Management Inc. cut its stake in ResMed Inc. (NYSE: RMD) by 13.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 265,399 shares of the medical equipment provider's stock after selling 41,557 shares during the period. ResMed

prnewswire.com · 21 jul

BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)

TROY, Mich., July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Broadridge Financial Resources Inc. (NYSE: BR) as its "Stock to Study" and ResMed Inc. (NYSE: RMD) as its "Undervalued Stock" in the October 2026 issue for investors' informational and educational use.

defenseworld.net · 21 jul

Baader Bank Aktiengesellschaft Trims Position in ResMed Inc. $RMD

Baader Bank Aktiengesellschaft decreased its stake in shares of ResMed Inc. (NYSE: RMD) by 61.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,768 shares of the medical equipment provider's stock after selling 7,696 shares during the quarter. Baader

zacks.com · 13 jul

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

zacks.com · 10 jul

Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care

RMD's MatrixCare sale sharpens its focus on sleep, breathing and connected care while freeing resources for AI-powered digital health.

benzinga.com · 9 jul

ResMed Analyst Backs Portfolio Reset

ResMed Inc. (NYSE:RMD) agreed to sell its MatrixCare business on Tuesday to Frazier Healthcare Partners, a private equity firm focused exclusively on health care, for $490 million.

zacks.com · 8 jul

Why ResMed (RMD) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

seekingalpha.com · 8 jul

Top 50 High-Quality Dividend Growth Stocks For July 2026

I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Year-to-date through June, the investable universe returned 8.69%, trailing SPY (10.10%) and SCHD (17.50%), but several individual stocks outperformed significantly. Currently, 39 out of 50 stocks offer a forward return estimate of at least 10%, with 22 appearing potentially undervalued by my free cash flow model.